An analytical perspective on favoured synthetic routes to the psychoactive tryptamines.
Simon D. Brandt, Sally Freeman, Peter McGagh, Norliza Abdul-Halim, John F. Alder
Journal of Pharmaceutical and Biomedical Analysis November 19, 2004 DOI: 10.1016/j.jpba.2004.08.022 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Key findings | Argues that analytical chemists need foundation chemistry and specific analytical targets to directly characterize tryptamine products and intermediates, and identifies likely side products and impurities of certain synthetic routes where literature reports are available, illustrating with recent examples from the authors' laboratory. |
Abstract
Many tryptamine derivatives are known to induce altered states of consciousness and are increasingly of interest in forensic and neurobiological studies. The analytical chemistry of certain synthetic routes to the tryptamines is discussed and likely side products and impurities identified, where literature reports are available. Recent examples from the authors' laboratory are presented to highlight future prospects and implications for analytical procedures. The aim of this review is to provide the analytical chemist with the foundation chemistry and some analytical targets to be able to undertake direct characterisation of products and intermediates. These might become available from interdiction of clandestine operations in a forensic environment or during the synthesis of the tryptamines for investigative neurobiological and clinical procedures.
Citations in the library
Cited by 10
- The hallucinogenic world of tryptamines: an updated review. Archives of Toxicology August 1, 2015
- Recreational Use, Analysis and Toxicity of Tryptamines Current Neuropharmacology December 10, 2014
- A general approach to the screening and confirmation of tryptamines and phenethylamines by mass spectral fragmentation. Talanta January 15, 2008
- Study of the in vitro and in vivo metabolism of the tryptamine 5‐MeO‐MiPT using human liver microsomes and real case samples Drug Testing and Analysis July 5, 2017
- Nonlinear pharmacokinetics of 5-methoxy-N,N-dimethyltryptamine in mice. Drug Metabolism and Disposition July 1, 2011
and 5 more in the library
Cites 9
- Improved Fischer Indole Reaction for the Preparation of N,N-Dimethyltryptamines: Synthesis of L-695,894, a Potent 5-HT1D Receptor Agonist The Journal of Organic Chemistry July 1, 1994
- Pharmahuasca: Human Pharmacology of Oral DMT Plus Harmine Journal of Psychoactive Drugs April 1, 1999
- Pharmepéna-Psychonautics: Human intranasal, sublingual and oral pharmacology of 5-methoxy-N,N-dimethyl-tryptamine. Journal of Psychoactive Drugs 2001
- Abwandlungsprodukte von Psilocybin und Psilocin. 2. Mitteilung über synthetische Indolverbindungen Helvetica Chimica Acta 1959
- Pharmañopo-psychonautics: human intranasal, sublingual, intrarectal, pulmonary and oral pharmacology of bufotenine. Journal of Psychoactive Drugs 2001
and 4 more in the library